Stelliam Investment Management LP cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% during the first quarter, Holdings Channel reports. The fund owned 257,500 shares of the healthcare conglomerate’s stock after selling 30,000 shares during the period. UnitedHealth Group accounts for approximately 1.6% of Stelliam Investment Management LP’s investment portfolio, making the stock its 29th largest position. Stelliam Investment Management LP’s holdings in UnitedHealth Group were worth $42,233,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Teachers Advisors LLC increased its stake in shares of UnitedHealth Group by 56.8% in the fourth quarter. Teachers Advisors LLC now owns 1,929,490 shares of the healthcare conglomerate’s stock valued at $308,796,000 after buying an additional 698,955 shares during the last quarter. Kentucky Retirement Systems bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at $11,054,000. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at $4,932,000. Searle & CO. bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at $537,000. Finally, Wsfs Capital Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at $1,728,000. 86.37% of the stock is owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down 0.83% during mid-day trading on Thursday, reaching $193.21. The company’s stock had a trading volume of 345,557 shares. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The company has a 50 day moving average price of $188.96 and a 200 day moving average price of $174.38. The stock has a market capitalization of $186.81 billion, a P/E ratio of 23.21 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.96 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Stelliam Investment Management LP Has $42.23 Million Stake in UnitedHealth Group Incorporated (UNH)” was reported by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/10/stelliam-investment-management-lp-has-42-23-million-stake-in-unitedhealth-group-incorporated-unh.html.

UNH has been the subject of several analyst reports. Mizuho upped their target price on UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Evercore ISI reaffirmed an “outperform” rating and issued a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Credit Suisse Group upped their target price on UnitedHealth Group from $185.00 to $188.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 19th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and issued a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $200.24.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the sale, the director now directly owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock worth $2,873,320 over the last ninety days. 0.89% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.